Edition:
United Kingdom

People: Mabion SA (MABP.WA)

MABP.WA on Warsaw Stock Exchange

77.60PLN
23 Aug 2019
Change (% chg)

1.10zł (+1.44%)
Prev Close
76.50zł
Open
75.00zł
Day's High
77.60zł
Day's Low
75.00zł
Volume
2,463
Avg. Vol
10,763
52-wk High
124.00zł
52-wk Low
66.00zł

Wieczorek, Maciej 

Dr. Maciej Wieczorek has been Chairman of the Supervisory Board of Mabion S.A. since 2018. He was Vice Chairman of the Supervisory Board of Mabion S.A. from March 31, 2017. He was Member of the Supervisory Board at the Company from February 16, 2017. He was Chairman of the Management Board of the Company from 2007 until December 14, 2016. He is Chairman of the Nominating and Remuneration Committee at the Company. In the past, he was responsible for the pharmaceutical sector within the BRE Bank group. Between 1995 and 2002, he served as Co-Owner and Vice President of Adamed, a Polish pharmaceutical company. Dr. Wieczorek has been Chairman of the Management Board of Celon Pharma S.A. He is author and co-author of several patents concerning chemical and biotechnological drugs. He holds a Doctorate of Medicine degree in Medical Biology from Uniwersytet Medyczny w Lodzi (2009), as well as a degree in Industrial Management from Politechnika Warszawska. Dr. Wieczorek has completed MBA studies program at Wyzsza Szkola Handlowa in Warsaw in cooperation with University of Minnesota. In addition, he has taken part in UE TEMPUS program and studied at Universidade Nova de Lisboa in Portugal.

Basic Compensation

Total Annual Compensation, PLN 14,667
Restricted Stock Award, PLN --
Long-Term Incentive Plans, PLN --
All Other, PLN --
Fiscal Year Total, PLN 14,667

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --